More relevant to anti-cancer treatments, disruption of an interaction between lysyl-tRNA synthetase (KARS) and the laminin receptor by a small molecule inhibitor was found to inhibit the metastatic progression of a mouse breast cancer model [87]. The gene discussed is KARS1; the disease is breast cancer.